Enhanced radiosensitization of human glioblastoma multiforme cells with phosphorylated peptides derived from Gli2

Area of Science:

• Oncology
• Molecular Biology
• Cancer Signaling

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor.
• Sonic Hedgehog (SHH) signaling pathway, regulated by Glioma-Associated Oncogene Family Zinc Finger 2 (Gli2), is crucial for GBM cell self-renewal and tumorigenesis.
• Targeting Gli2 offers a potential therapeutic strategy for GBM.

Purpose of the Study:

• To investigate the efficacy of phosphorylated Gli2 peptides in radiosensitizing GBM cells.
• To evaluate the impact of these peptides on Gli2 transcriptional activity and GBM cell survival.

Main Methods:

• Synthesis of three phosphorylated peptides derived from Gli2, combined with a cell-penetrating peptide.
• Western Blotting to assess Gli2 phosphorylation levels.
• Luciferase reporter assay to measure Gli2 transcriptional activity.
• Clonogenic survival and apoptosis assays to determine radiosensitization effects.

Main Results:

• A combination of three phosphorylated Gli2 peptides significantly increased Gli2 phosphorylation compared to individual peptides.
• The mixed peptides markedly reduced Gli2 transcriptional activity.
• The combined phosphorylated peptides demonstrated enhanced radiosensitizing effects on GBM cells in vitro.

Conclusions:

• Phosphorylated Gli2 peptides represent a novel strategy to inhibit Gli2 transcriptional activity.
• This approach can effectively radiosensitize Glioblastoma multiforme cells, offering a potential new therapeutic avenue.